FIELD: medicine.
SUBSTANCE: invention relates to medicine and concerns a method for pathogenetic correction of metabolic disorders in infectious mononucleosis caused by Epstein-Barr virus, including drug-induced therapy, namely agents of etiotropic, pathogenetic, symptomatic therapy, wherein patient is prescribed azoxymer bromide preparation (Polyoxidonium) in dosage 12 mg sublingually 2 times a day in acute period of disease, 1–7 days of disease.
EFFECT: invention provides effective control of infectious mononucleosis, eliminated development of serious complications and transition to chronic form, reduced length of hospital stay.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING THERAPEUTIC APPROACH IN CHILDREN WITH ACUTE INFECTIOUS MONONUCLEOSIS | 2023 |
|
RU2821347C1 |
| METHOD OF DIFFERENTIAL EXPRESS DIAGNOSTICS OF ACUTE VIRAL AND BACTERIAL INFECTIONS | 2015 |
|
RU2602677C1 |
| METHOD FOR TREATMENT OF LYMPHOADENOPATHY | 2002 |
|
RU2217146C2 |
| METHOD FOR ASSESSING DEGREE OF INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2017 |
|
RU2673073C1 |
| METHOD FOR DIAGNOSIS OF INFECTION CAUSED BY EPSTEIN-BARR VIRUS | 2002 |
|
RU2247390C2 |
| METHOD FOR DETERMINATION OF SEVERITY OF INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN - BARR VIRUS IN ADULTS | 2017 |
|
RU2639596C1 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF INFECTIOUS MONONUCLEOSIS OF EPSHTEIN-BARR-VIRAL ETIOLOGY, ACUTE BACTERIAL TONSILLITIS AND ACUTE VIRAL HEPATITIS “B” IN ADULTS | 2017 |
|
RU2687563C2 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF INFECTIOUS MONONUCLEOSIS OF VARIOUS ETIOLOGY AT CHILDREN | 2008 |
|
RU2360254C1 |
| METHOD OF TREATMENT OF PATIENTS WITH INFECTIOUS DISEASES COMPLICATED BY ANGINA SYNDROME | 1996 |
|
RU2139727C1 |
| METHOD FOR DETERMINING AETIOLOGY OF TONSILLITIS IN CHILDREN | 2012 |
|
RU2494398C1 |
